Speaker Name / Credentials
Kevin C. Maki, PhD, CLS, FNLA, FTOS, FACN
Midwest Center for Metabolic & Cardiovascular Research, Chicago, Illinois
Estimated time of Talk
This webinar will review the National Lipid Association recommendations for dietary modifications intended to lower levels of atherogenic cholesterol [low-density lipoprotein cholesterol (LDL-C) and non-high-density lipoprotein cholesterol (non-HDL-C)], with an emphasis on dietary adjuncts to a diet low in saturated fats, trans fats, and cholesterol.
- Review lipids and lipoproteins and their relationship to atherosclerotic cardiovascular disease (ASCVD) risk.
- Discuss genetic variants associated with altered lipoprotein profiles and their relationships to ASCVD risk.
- Discuss how dietary adjuncts, with or without pharmacological intervention, work to lower levels of LDL-C and non-HDL-C.
- Review the effects of a combining a “portfolio” of dietary strategies on circulating levels of atherogenic cholesterol.
Dr. Maki is on the scientific advisory board or has consulted for AstraZeneca, Pharmavite, Matinas BioPharma, Sancilio & Co., National Dairy Council, Egg Nutrition Center, and National Cattlemen’s Beef Association and has received research grants from DuPont, AstraZeneca, AbbVie, ACH Foods, Matinas BioPharma, Shaklee, Egg Nutrition Center, National Dairy Council, National Cattlemen’s Beef Association and Sancilio & Co.